Magellan Health Appoints Tim Lacy as Chief Growth Officer
April 06 2020 - 6:30AM
Business Wire
Magellan Health, Inc. (NASDAQ: MGLN) today announced it has
appointed Tim Lacy as chief growth officer of Magellan Health,
effective Monday, April 6, 2020.
In this newly created role, Lacy will be responsible for driving
a collaborative approach with Magellan Health business leaders and
customers to transform end-to-end sales processes, ensure the
Company continues to create and deliver differentiated solutions
and capabilities, as well as gain and retain competitive advantage
and market leadership.
“I look forward to leveraging Tim’s tremendous sales and
business development expertise as we seek to enhance the overall
growth strategy for our Company,” said Ken Fasola, chief executive
officer, Magellan Health. “In this key role, he will partner
closely with me and our business leaders as we set the road map for
a sales strategy firmly synched to market demands and the
achievement of our business and financial growth goals.”
“I am honored and energized by the opportunity to work closely
with Ken and the leadership team to capture the next phase of
growth for Magellan Health,” said Lacy. “As we bring new
capabilities and programs to market, we will solidify our role as a
leader in the behavioral and physical health space and bring
meaningful value to our customers, members and shareholders.”
Lacy is a proven leader in the healthcare industry with over 27
years of experience in managing national sales activities, sales
operations and corporate development for Fortune 100 companies
including UnitedHealth Group and Walgreens. Prior to joining
Magellan Health, he was a managing partner at FlagshipHealth Group
for nearly 10 years providing expert counsel on go-to-market
strategies for large health systems and health plans. Lacy has a
Bachelor of Science degree in International and Business Management
from St. John’s University.
About Magellan Health: Magellan Health, Inc., a Fortune
500 company, is a leader in managing the fastest growing, most
complex areas of health, including special populations, complete
pharmacy benefits and other specialty areas of healthcare. Magellan
supports innovative ways of accessing better health through
technology, while remaining focused on the critical personal
relationships that are necessary to achieve a healthy, vibrant
life. Magellan's customers include health plans and other managed
care organizations, employers, labor unions, various military and
governmental agencies and third-party administrators. For more
information, visit MagellanHealth.com.
Forward-Looking Statements All statements, other than
statements of current or historical fact, contained in this press
release are forward-looking statements. Magellan intends such
forward-looking statements to be covered by the safe-harbor
provisions for forward-looking statements contained in the Private
Securities Litigation Reform Act of 1995, and we are including this
statement for purposes of complying with these safe-harbor
provisions. These statements are based on management’s analysis,
judgment, belief and expectation only as of the date hereof, and
are subject to uncertainty and changes in circumstances. Without
limiting the foregoing, the words “believes,” “anticipates,”
“plans,” “expects,” “may,” “should,” “could,” “estimate,” “intend”
and other similar expressions are intended to identify
forward-looking statements. You should not place undue reliance on
any forward-looking statements, as actual results may differ
materially from projections, estimates, or other forward-looking
statements due to a variety of factors, variables and events
including but not limited to: the impact of COVID-19 on global
markets, economic conditions and the healthcare industry and our
results of operations, which is unknown; the possible election of
certain of the Company’s customers to manage the healthcare
services of their members directly; changes in rates paid to and/or
by the Company by customers and/or providers; higher utilization of
healthcare services by the Company’s risk members; risks and
uncertainties associated with the pharmacy benefits management
industry; delays, higher costs or inability to implement new
business or other Company initiatives; the impact of changes in the
contracting model for Medicaid contracts; termination or
non-renewal of customer contracts; the impact of new or amended
laws or regulations; governmental inquiries; litigation;
competition; operational issues; healthcare reform; and general
business conditions. Additional factors that could cause actual
results to differ materially from those reflected in the
forward-looking statements include, but are not limited to, the
risks discussed in the “Risk Factors” section included within the
Company’s Annual Report on Form 10-K for the year ended December
31, 2019, filed with the Securities and Exchange Commission on
February 28, 2020. The Company undertakes no obligation to publicly
revise these forward-looking statements to reflect events or
circumstances that arise after the date of this release.
(MGLN-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200406005179/en/
Media Contact: Lilly Ackley, ackleyl@magellanhealth.com,
(860) 507-1923 Investor Contact: Joe Bogdan,
jbogdan@magellanhealth.com, (860) 507-1910
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Apr 2023 to Apr 2024